Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) FCF Margin (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed FCF Margin for 2 consecutive years, with 109000.0% as the latest value for Q3 2025.

  • Quarterly FCF Margin fell 10792092.0% to 109000.0% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 80687.5% through Dec 2025, down 8059392.0% year-over-year, with the annual reading at 80687.5% for FY2025, 8059392.0% down from the prior year.
  • FCF Margin hit 109000.0% in Q3 2025 for Connect Biopharma Holdings, down from 26862.5% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 33.11% in Q2 2024 to a low of 109000.0% in Q3 2025.